Form 4: AbbVie Director Susan E. Quaggin Reports Stock Equivalent Unit Transactions

Director Susan E. Quaggin reports acquisition of AbbVie stock equivalent units through director fees and dividend reinvestment.

Summary

• Susan E. Quaggin, a director of AbbVie Inc., filed a Form 4 detailing changes in her beneficial ownership.
• On March 31, 2024, she acquired 82 stock equivalent units at $182.1 each as director fees credited to a grantor trust.
• These units earn the same return as if invested in AbbVie stock and are paid in cash generally at age 65 or upon retirement from the board.
• The balance of her holdings includes stock equivalent units acquired through a dividend reinvestment feature, totaling 147 units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company through stock equivalent units and dividend reinvestment.

Positives

• The acquisition of stock equivalent units demonstrates the director's continued investment in AbbVie's future.
• Dividend reinvestment indicates a long-term commitment to the company's success.

Future Outlook

The director's stock equivalent units will be paid out in cash generally at age 65 or upon retirement from the board.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the director's holdings and investment activity.

Key Dates